BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11243810)

  • 21. Mutational analysis of avidity and fine specificity of anti-levan antibodies.
    Brorson K; Thompson C; Wei G; Krasnokutsky M; Stein KE
    J Immunol; 1999 Dec; 163(12):6694-701. PubMed ID: 10586066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
    Chin LT; Chu C; Chen HM; Hsu SC; Weng BC; Chu CH
    BMC Biotechnol; 2007 Aug; 7():51. PubMed ID: 17714596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
    Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
    J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies.
    Krishnan MR; Marion TN
    J Immunol; 1993 Jun; 150(11):4948-57. PubMed ID: 8496596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
    Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
    Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigen.
    Haley J; Mason LJ; Nagl S; Giles I; Latchman DS; Isenberg DA; Rahman A
    Mol Immunol; 2004 Jan; 40(11):745-58. PubMed ID: 14687932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies.
    Gilkeson GS; Bernstein K; Pippen AM; Clarke SH; Marion T; Pisetsky DS; Ruiz P; Lefkowith JB
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):59-67. PubMed ID: 7606869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant shark natural antibodies to thyroglobulin.
    Schluter SF; Jensen I; Ramsland PA; Marchalonis JJ
    J Mol Recognit; 2005; 18(5):404-12. PubMed ID: 15954089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis.
    Ravirajan CT; Rahman MA; Papadaki L; Griffiths MH; Kalsi J; Martin AC; Ehrenstein MR; Latchman DS; Isenberg DA
    Eur J Immunol; 1998 Jan; 28(1):339-50. PubMed ID: 9485213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
    Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
    Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of human anti-double-stranded DNA autoantibodies.
    Wellmann U; Letz M; Herrmann M; Angermüller S; Kalden JR; Winkler TH
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9258-63. PubMed ID: 15968001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the interaction between a high-affinity single-chain Fv and a pyrimidine (6-4) pyrimidone photodimer by site-directed mutagenesis.
    Kobayashi H; Morioka H; Tobisawa K; Torizawa T; Kato K; Shimada I; Nikaido O; Stewart JD; Ohtsuka E
    Biochemistry; 1999 Jan; 38(2):532-9. PubMed ID: 9888792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial expression of anti-DNA antibody domains.
    Stollar BD
    Methods; 1997 Jan; 11(1):12-9. PubMed ID: 8990084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The creation of diversity in the human immunoglobulin V(lambda) repertoire.
    Ignatovich O; Tomlinson IM; Jones PT; Winter G
    J Mol Biol; 1997 Apr; 268(1):69-77. PubMed ID: 9149142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA.
    Li Z; Schettino EW; Padlan EA; Ikematsu H; Casali P
    Eur J Immunol; 2000 Jul; 30(7):2015-26. PubMed ID: 10940891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic origins of anti-DNA autoantibodies].
    Eilat D
    Ann Med Interne (Paris); 1990; 141(3):205-7. PubMed ID: 2369008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies.
    Acierno JP; Braden BC; Klinke S; Goldbaum FA; Cauerhff A
    J Mol Biol; 2007 Nov; 374(1):130-46. PubMed ID: 17916365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.